Thoracic Epidural Anesthesia in Cardiac Surgery: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials

Author:

Chiew John Keong1,Low Christopher Jer Wei1,Zeng Kieran2,Goh Zhi Jie3,Ling Ryan Ruiyang1,Chen Ying14,Ti Lian Kah15,Ramanathan Kollengode16

Affiliation:

1. Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, Singapore

2. Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia

3. Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore

4. Agency of Science, Technology and Research, Singapore

5. Department of Anaesthesia, National University Hospital, National University Health System, Singapore

6. Department of Cardiac, Thoracic and Vascular Surgery, Cardiothoracic Intensive Care Unit, National University Heart Centre, National University Hospital, National University Health System, Singapore.

Abstract

BACKGROUND: Research on fast-track recovery protocols postulates that thoracic epidural anesthesia (TEA) in cardiac surgery contributes to improved postoperative outcomes. However, concerns about TEA’s safety hinder its widespread usage. We conducted a systematic review and meta-analysis to assess the benefits and risks of TEA in cardiac surgery. METHODS: We searched 4 databases for randomized controlled trials (RCTs) assessing the use of TEA against only general anesthesia (GA) in adults undergoing cardiac surgery, up till June 4, 2022. We conducted random-effects meta-analyses, evaluated risk of bias using the Cochrane Risk-of-Bias 2 tool, and rated certainty of evidence via the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach. Primary outcomes were intensive care unit (ICU), hospital length of stay, extubation time (ET), and mortality. Other outcomes included postoperative complications. Trial sequential analysis (TSA) was conducted on all outcomes to elicit statistical and clinical benefit. RESULTS: Our meta-analysis included 51 RCTs (2112 TEA patients and 2220 GA patients). TEA significantly reduced ICU length of stay (−6.9 hours; 95% confidence interval [CI], −12.5 to −1.2; P = .018), hospital length of stay (−0.8 days; 95% CI, −1.1 to −0.4; P < .0001), and ET (−2.9 hours; 95% CI, −3.7 to −2.0; P < .0001). However, we found no significant change in mortality. TSA found that the cumulative Z-curve passed the TSA-adjusted boundary for ICU length of stay, hospital length of stay, and ET, suggesting a clinical benefit. TEA also significantly reduced pain scores, pooled pulmonary complications, transfusion requirements, delirium, and arrhythmia, without additional complications such as epidural hematomas, of which the risk was estimated to be <0.14%. CONCLUSIONS: TEA reduces ICU and hospital length of stay, and postoperative complications in patients undergoing cardiac surgery with minimal reported complications such as epidural hematomas. These findings favor the use of TEA in cardiac surgery and warrant consideration for use in cardiac surgeries worldwide.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference90 articles.

1. Global unmet needs in cardiac surgery.;Zilla;Glob Heart,2018

2. Trends and outcomes for cardiac surgery in the United Kingdom from 2002 to 2016.;Grant;JTCVS Open,2021

3. One-year results from the first US-based enhanced recovery after cardiac surgery (ERAS Cardiac) program.;Williams;J Thorac Cardiovasc Surg,2019

4. Epidural analgesia for adults undergoing cardiac surgery with or without cardiopulmonary bypass.;Guay;Cochrane Database of Syst Rev,2019

5. High thoracic epidural blockade increases myocardial oxygen availability in coronary surgery patients.;Lagunilla;Acta Anaesthesiol Scand,2006

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. UpToDate®;ASA Monitor;2024-02-01

2. SEE Question;ASA Monitor;2024-02-01

3. Regional Anesthesia for Cardiac Surgery;Advances in Regional Anesthesia [Working Title];2023-10-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3